Menu

ImmunityBio, Inc. IBRX

Full chart Compare
Set alert

Price alert · IBRX

All alert types
6.09 USD -0.59 (-8.77%)

Nov 12, 2026, 3:44 PM EST

6.00 Day range 6.50
1.95 52-week range 12.43
YTD
+207.32%
1 year
+195.39%

Discussion (3506)

Sign in to join the discussion

frank fager IBRX 6 months ago #1351

New highs would be more like $45 which can easily happen. With deletion of shares maybe new would be more like $30 not sure and not going to try to figure it out or do the math.

frank fager IBRX 6 months ago #1352

Paul Silberberg is the only person posting that is worth reading the rest of us are laypeople myself included

frank fager IBRX 6 months ago #1353

Disclose

So I know who I am taking advice from

frank fager IBRX 6 months ago #1354

Let's all disclose the number of shares owned I will go first

550,000 PS average $5.19 so 2.85 million invested

frank fager IBRX 6 months ago #1355

Mark

Merck could offer $100 Dr. PSS would tell them to go fuck themselves. He hates big pharma and corporate healthcare and the main stream media too.

frank fager IBRX 6 months ago #1356

I have an idea buy 1500 shares at 7.85 and sell at 8.10 make $375 lmao do it over and over and over get rich

frank fager IBRX 6 months ago #1357

This stock IBRX will be $50-$100 in 5 years

ImmunityBio I predict will be the largest biopharma in the world

frank fager IBRX 6 months ago #1358

Buy out buy out

NEVER HAPPEN

OMG ImmunityBio will be buying out companies someday! That's more likely you are fools.

frank fager IBRX 6 months ago #1359

Omg the buy out BS has resurfaced. OMG Olympic gold medal stupid. Dr. PSS isn't turning his life time work over to a Big Pharma crime organization. He is worth billions and only cares about curing cancer, saving lives and curing disease. He would never give up control to an immoral Big Pharma.

frank fager IBRX 6 months ago #1360

ImmunityBio I believe will be the largest biopharmaceutical company in the world.

Share price someday $100-$300 a share.

Why Anktiva isn't a single cancer specific drug and it can be used to treat acute and chronic infections. So the market size has no limit.